Brief: Biosergen Q3 Net Loss Widens To SEK 14.5 Mln
30/11/2022 09:51
Nov 30 (Reuters) - Biosergen AB BIOSGN.ST :
* Q3 LOSS FOR PERIOD SEK 14.5 MILLION VERSUS LOSS SEK 6.6
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr1rfrJ0
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million